» Articles » PMID: 12594672

Smoking Affects the Outcome of Transanal Mucosal Advancement Flap Repair of Trans-sphincteric Fistulas

Overview
Journal Br J Surg
Specialty General Surgery
Date 2003 Feb 21
PMID 12594672
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of the study was to identify variables affecting the outcome of transanal advancement flap repair (TAFR) for perianal fistulas of cryptoglandular origin.

Methods: Between 1995 and 2000, a consecutive series of 105 patients (65 women, 40 men), with a median age of 44 (range 19-72) years was included in the study. The patients were recruited from the colorectal departments of two university medical centres. Patients with a rectovaginal fistula and those with a fistula due to Crohn's disease were excluded. The following variables were assessed: age, sex, number of previous attempts at repair, preoperative seton drainage, fistula type, presence of horseshoe extensions, location of the internal opening, postoperative drainage, body mass index and the number of cigarettes smoked per day. The results were analysed by means of multiple logistic regression.

Results: The median follow-up was 14 months. No differences were observed between the two centres. TAFR was successful in 72 patients (69 per cent). None of the variables affected the outcome of the procedure, except for smoking habit of the patient. In patients who smoked the observed healing rate was 60 per cent, whereas a rate of 79 per cent was found in patients who did not smoke. This difference was statistically significant (P = 0.037). Moreover, a significant correlation was observed between the number of cigarettes smoked per day and the healing rate (P = 0.003).

Conclusion: Cigarette smoking affects the outcome of TAFR in patients with a cryptoglandular perianal fistula.

Citing Articles

Additional Intraoperative Autologous-Derived Platelet-Rich Stroma to Transanal Flap Repair for the Treatment of Cryptoglandular Transsphincteric Fistulas in a Tertiary Referral Center: Long-Term Outcomes of a Prospective Pilot Study.

Bak M, Witjes C, Dwarkasing R, Arkenbosch J, Schouten W, van Veen J Bioengineering (Basel). 2025; 12(2).

PMID: 40001625 PMC: 11851975. DOI: 10.3390/bioengineering12020105.


Navigating the complexities of perianal Crohn's disease: Diagnostic strategies, treatment approaches, and future perspectives.

Singh J, Aleissa M, Drelichman E, Mittal V, Bhullar J World J Gastroenterol. 2024; 30(44):4745-4753.

PMID: 39610776 PMC: 11580605. DOI: 10.3748/wjg.v30.i44.4745.


Evaluating occult causes of disease: the tricompartmental PNEI approach and the importance of the microbiome.

Pescatori M Tech Coloproctol. 2024; 28(1):36.

PMID: 38381266 DOI: 10.1007/s10151-023-02901-3.


Surgery for anal fistulae: state of the art.

Pescatori M Int J Colorectal Dis. 2021; 36(10):2071-2079.

PMID: 34057576 DOI: 10.1007/s00384-021-03917-7.


Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon's Point of View.

Lee J, Yoon Y, Yu C Ann Coloproctol. 2021; 37(1):5-15.

PMID: 33730796 PMC: 7989558. DOI: 10.3393/ac.2021.02.08.